Introduction: COVID-19 claimed millions of lives, mainly in the pre-vaccine era. Preliminary studies showed promising efficacy of convalescent plasma against SARS-CoV-2 (CP).
Objective: To evaluate the efficacy of CP in patients hospitalized for COVID-19 with moderate severity.